Maxcyte MXCT
NASDAQ MXCT
$1.32 +0.02 (+1.15%)
As of: Oct 20, 2026 · 12:28 PM EDT

Maxcyte (MXCT) Debt Ratio (2020)

Updated

Maxcyte's (MXCT) Debt Ratio stood at 0.09 in Q4 2020.

Analysis

Maxcyte (MXCT) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 254.77 Bn 233.80 Bn 4.88 Bn 0.38
2 Abbott Laboratories 178.96 Bn 149.39 Bn 7.27 Bn 0.30
3 Danaher 159.51 Bn 143.32 Bn 3.61 Bn 0.29
4 Intuitive Surgical 154.43 Bn 133.86 Bn 1.96 Bn -
5 Medtronic 120.60 Bn 85.85 Bn 6.34 Bn 0.30
6 Stryker 116.24 Bn 102.36 Bn 4.50 Bn 0.31
7 Boston Scientific 66.79 Bn 61.56 Bn 3.85 Bn 0.28
8 Becton Dickinson 53.07 Bn 50.22 Bn 2.32 Bn 0.33
9 Edwards Lifesciences 50.67 Bn 34.67 Bn 1.35 Bn 0.04
10 Maxcyte 140.47 Mn -280.84 Mn 5.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 0.09
API Access

Maxcyte Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MXCT&period=max&api_key=YOUR_API_KEY